Global Cardiopulmonary Autotransfusion Devices Market by Type (On-Pump Transfusion Device, Off-Pump Transfusion Device), By Application (Hospitals, Ambulatory Surgical Center, Cardiac Research Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The Global Cardiopulmonary Autotransfusion Devices Market size was valued at $1.82 billion in 2019 and is projected to reach a value of $2.62 billion by 2028, at a CAGR of 5%. The on-pump transfusion device segment will lead the market with a share of 32% and an estimated value of $890 million by 2028. The factors driving growth in this market are the increasing incidence of cardiovascular diseases, the growing adoption rate of minimally invasive procedures, and technological advancements in medical equipment.
A Cardiopulmonary Autotransfusion device is a medical device that provides blood circulation from the donor to the recipient. Cardiopulmonary autotransfusion devices are used to perform cardiopulmonary bypass in cardiac surgery procedures. They work by giving a patient an oxygen-rich blood supply, which is then drained of carbon dioxide and saturates the tissues with nutrients and other substances that will eventually be needed for healing.
On the basis of Type, the market is segmented into On-Pump Transfusion Device and Off-Pump Transfusion Device. The on-pump transfusion device accounted for the largest share owing to its ease of use, which is a key factor in choosing this type.
On-Pump Transfusion Device:
An on-pump transfusion device is a kind of cardiopulmonary autotransfusion (CPAT) device that inverts the blood flow pattern. It is considered as an artificial heart and lungs, but it does not have its own pumping system. Instead, what makes it possible for CPAT to work are the external pumps which can be connected through tubes or hoses. This pump forces oxygenated blood from the right ventricle into both atria and returns it back to the left ventricle which then sends this now deoxygenated blood onto the rest of the body via systemic circulation.
Off-Pump Transfusion Device:
Off-Pump Transfusion Devices are devices used for blood transfusions in patients who have been taken off cardiopulmonary bypass, but still, need a continuous flow of blood. Off-pump transcutaneous and percussive circulatory assist systems (PCAS) provide this support when the heart stops pumping on its own or is too weak to do so adequately enough.
The PCAS provides cardiac output by creating an artificial heartbeat with gentle vibrations that doesn’t overwork the patient’s remaining myocardium or cause clotting in their lower body circulation like a mechanical pump does. This type of device may be necessary for critically ill patients who rely solely on cardiopulmonary bypass during surgery.
On the basis of Application, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Cardiac Research Centers. The market for application in hospitals is expected to grow at the fastest rate during the forecast period on account of their rising adoption.
Cardiopulmonary Autotransfusion is used in hospitals as a life-saving procedure to provide blood in emergency situations when there is a shortage. Cardiopulmonary Autotransfusion is used as an alternative for patients with injuries or diseases that prevent the patient from undergoing regular surgery, who need an organ transplant, or whose major organs are failing and cannot be replaced by conventional means. These include trauma victims; people needing kidney transplants; those awaiting other surgeries such as liver replacement because of complications caused by cirrhosis.
The use of Cardiopulmonary Autotransfusion devices in the ambulatory surgical centers market is expected to grow significantly, which will drive the growth for this segment during the forecast period. The high adoption rate and rising incidence rates of cardiovascular diseases such as hypertension are likely to increase demand for cardiopulmonary autotransfusion devices in hospitals across all regions during the forecast period.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market accounted for a major share of the global market in 2017. The U.S., Canada, and Mexico are some of the major contributors to this regional segmentation. In the Asia Pacific, Japan is one of the largest markets which posted considerable growth rates during 2016-2017. China has also been an attractive destination for many manufacturers due to its increasing demand for cardiopulmonary devices.
The Latin American region had achieved remarkable development as Brazil was predicted to be among the top five countries with the highest CPD sales volume by 2020. Europe accounted for about 15% of the total market size and expected to dominate over other regions until 2028 owing to technological innovations coming up from various European vendors.
Growth Factors For The Global Cardiopulmonary Autotransfusion Devices Market:
Despite the global economic slowdown, the cardiopulmonary autotransfusion devices market is expected to grow during 2021-2028 because of the increasing incidence of cardiac diseases and the high demand for blood transfusions in emerging economies such as China, India, and Brazil. Additionally, increased awareness about self-donation by promoting user-friendly donation methods will also drive the growth of the market during the forecast period. Furthermore, rising prevalence rates for chronic pulmonary conditions like COPD could lead to additional usage among patients with a low respiratory reserve who are unable to tolerate conventional oxygen therapy or mechanical ventilation on their own behalf; hence it would provide them access to manual chest compressions that can be performed even outside hospital setting without any support.
Up Market Research published a new report titled “Cardiopulmonary Autotransfusion Devices Market research report which is segmented by Types (On-Pump Transfusion Device, Off-Pump Transfusion Device), By Applications (Hospitals, Ambulatory Surgical Center, Cardiac Research Centers), By Players/Companies Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Stryker, Atrium Medical”.
Report Scope
| Report Attributes | Report Details |
| Report Title | Cardiopulmonary Autotransfusion Devices Market Research Report |
| By Type | On-Pump Transfusion Device, Off-Pump Transfusion Device |
| By Application | Hospitals, Ambulatory Surgical Center, Cardiac Research Centers |
| By Companies | Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Stryker, Atrium Medical |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 200 |
| Number of Tables & Figures | 140 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Cardiopulmonary Autotransfusion Devices Market Report Segments:
The market is segmented by Type On-Pump Transfusion Device, Off-Pump Transfusion Device and By Application Hospitals, Ambulatory Surgical Center, Cardiac Research Centers.
Some of the companies that are profiled in this report are:
- Fresenius Kabi
- Haemonetics
- LivaNova
- Medtronic
- Terumo
- Stryker
- Atrium Medical
Cardiopulmonary Autotransfusion Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cardiopulmonary Autotransfusion Devices Market
Overview of the regional outlook of the Cardiopulmonary Autotransfusion Devices Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Cardiopulmonary Autotransfusion Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Cardiopulmonary Autotransfusion Devices Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. On-Pump Transfusion Device
2. Off-Pump Transfusion Device
7. By Application:1. Hospitals
2. Ambulatory Surgical Center
3. Cardiac Research Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiopulmonary Autotransfusion Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Cardiopulmonary Autotransfusion Devices Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiopulmonary Autotransfusion Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiopulmonary Autotransfusion Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiopulmonary Autotransfusion Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiopulmonary Autotransfusion Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiopulmonary Autotransfusion Devices Market Size & Forecast, 2018-2028
4.5.1 Cardiopulmonary Autotransfusion Devices Market Size and Y-o-Y Growth
4.5.2 Cardiopulmonary Autotransfusion Devices Market Absolute $ Opportunity
Chapter 5 Global Cardiopulmonary Autotransfusion Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
5.2.1 On-Pump Transfusion Device
5.2.2 Off-Pump Transfusion Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiopulmonary Autotransfusion Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Center
6.2.3 Cardiac Research Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiopulmonary Autotransfusion Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiopulmonary Autotransfusion Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiopulmonary Autotransfusion Devices Analysis and Forecast
9.1 Introduction
9.2 North America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
9.6.1 On-Pump Transfusion Device
9.6.2 Off-Pump Transfusion Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Center
9.10.3 Cardiac Research Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiopulmonary Autotransfusion Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
10.6.1 On-Pump Transfusion Device
10.6.2 Off-Pump Transfusion Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Center
10.10.3 Cardiac Research Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiopulmonary Autotransfusion Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
11.6.1 On-Pump Transfusion Device
11.6.2 Off-Pump Transfusion Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Center
11.10.3 Cardiac Research Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiopulmonary Autotransfusion Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
12.6.1 On-Pump Transfusion Device
12.6.2 Off-Pump Transfusion Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Center
12.10.3 Cardiac Research Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiopulmonary Autotransfusion Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
13.6.1 On-Pump Transfusion Device
13.6.2 Off-Pump Transfusion Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Center
13.10.3 Cardiac Research Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiopulmonary Autotransfusion Devices Market: Competitive Dashboard
14.2 Global Cardiopulmonary Autotransfusion Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Kabi
14.3.2 Haemonetics
14.3.3 LivaNova
14.3.4 Medtronic
14.3.5 Terumo
14.3.6 Stryker
14.3.7 Atrium Medical
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiopulmonary Autotransfusion Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiopulmonary Autotransfusion Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiopulmonary Autotransfusion Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiopulmonary Autotransfusion Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiopulmonary Autotransfusion Devices Market Size & Forecast, 2018-2028
4.5.1 Cardiopulmonary Autotransfusion Devices Market Size and Y-o-Y Growth
4.5.2 Cardiopulmonary Autotransfusion Devices Market Absolute $ Opportunity
Chapter 5 Global Cardiopulmonary Autotransfusion Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
5.2.1 On-Pump Transfusion Device
5.2.2 Off-Pump Transfusion Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiopulmonary Autotransfusion Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Center
6.2.3 Cardiac Research Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiopulmonary Autotransfusion Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiopulmonary Autotransfusion Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiopulmonary Autotransfusion Devices Analysis and Forecast
9.1 Introduction
9.2 North America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
9.6.1 On-Pump Transfusion Device
9.6.2 Off-Pump Transfusion Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Center
9.10.3 Cardiac Research Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiopulmonary Autotransfusion Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
10.6.1 On-Pump Transfusion Device
10.6.2 Off-Pump Transfusion Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Center
10.10.3 Cardiac Research Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiopulmonary Autotransfusion Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
11.6.1 On-Pump Transfusion Device
11.6.2 Off-Pump Transfusion Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Center
11.10.3 Cardiac Research Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiopulmonary Autotransfusion Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
12.6.1 On-Pump Transfusion Device
12.6.2 Off-Pump Transfusion Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Center
12.10.3 Cardiac Research Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiopulmonary Autotransfusion Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiopulmonary Autotransfusion Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiopulmonary Autotransfusion Devices Market Size Forecast by Type
13.6.1 On-Pump Transfusion Device
13.6.2 Off-Pump Transfusion Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiopulmonary Autotransfusion Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Center
13.10.3 Cardiac Research Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiopulmonary Autotransfusion Devices Market: Competitive Dashboard
14.2 Global Cardiopulmonary Autotransfusion Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Kabi
14.3.2 Haemonetics
14.3.3 LivaNova
14.3.4 Medtronic
14.3.5 Terumo
14.3.6 Stryker
14.3.7 Atrium Medical
Segments Covered in the Report
The global Cardiopulmonary Autotransfusion Devices market has been segmented based on
By Types
The global Cardiopulmonary Autotransfusion Devices market has been segmented based on
By Types
- On-Pump Transfusion Device
- Off-Pump Transfusion Device
- Hospitals
- Ambulatory Surgical Center
- Cardiac Research Centers
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Fresenius Kabi
- Haemonetics
- LivaNova
- Medtronic
- Terumo
- Stryker
- Atrium Medical
Our Clients
Related Reports
Some other reports from this category!
